Annual Total Debt
$26.99 M
-$23.47 M-46.51%
December 31, 2023
Summary
- As of February 8, 2025, UBX annual total debt is $26.99 million, with the most recent change of -$23.47 million (-46.51%) on December 31, 2023.
- During the last 3 years, UBX annual total debt has fallen by -$36.51 million (-57.49%).
- UBX annual total debt is now -57.49% below its all-time high of $63.50 million, reached on December 31, 2020.
Performance
UBX Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$20.70 M
-$961.00 K-4.44%
September 30, 2024
Summary
- As of February 8, 2025, UBX quarterly total debt is $20.70 million, with the most recent change of -$961.00 thousand (-4.44%) on September 30, 2024.
- Over the past year, UBX quarterly total debt has dropped by -$3.73 million (-15.28%).
- UBX quarterly total debt is now -67.40% below its all-time high of $63.50 million, reached on December 31, 2020.
Performance
UBX Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
UBX Total Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -46.5% | -15.3% |
3 y3 years | -57.5% | -59.0% |
5 y5 years | +100.0% | -59.0% |
UBX Total Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -51.8% | at low | -63.0% | at low |
5 y | 5-year | -57.5% | -100.0% | -67.4% | -100.0% |
alltime | all time | -57.5% | -100.0% | -67.4% | -100.0% |
Unity Biotechnology Total Debt History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $20.70 M(-4.4%) |
Jun 2024 | - | $21.66 M(-4.2%) |
Mar 2024 | - | $22.61 M(-16.2%) |
Dec 2023 | $26.99 M(-46.5%) | $26.99 M(+10.5%) |
Sep 2023 | - | $24.43 M(-43.3%) |
Jun 2023 | - | $43.08 M(-8.0%) |
Mar 2023 | - | $46.83 M(-7.2%) |
Dec 2022 | $50.46 M(-9.8%) | $50.46 M(+5.5%) |
Sep 2022 | - | $47.83 M(-1.0%) |
Jun 2022 | - | $48.33 M(-0.8%) |
Mar 2022 | - | $48.71 M(-12.9%) |
Dec 2021 | $55.94 M(-11.9%) | $55.94 M(+0.1%) |
Sep 2021 | - | $55.90 M(-1.8%) |
Jun 2021 | - | $56.93 M(-1.8%) |
Mar 2021 | - | $57.96 M(-8.7%) |
Dec 2020 | $63.50 M | $63.50 M(+5.9%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2020 | - | $59.95 M(+63.0%) |
Jun 2020 | - | $36.77 M(-3.0%) |
Mar 2020 | - | $37.89 M(>+9900.0%) |
Dec 2019 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2019 | - | $0.00(0.0%) |
Jun 2019 | - | $0.00(0.0%) |
Mar 2019 | - | $0.00(0.0%) |
Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2018 | - | $0.00(0.0%) |
Jun 2018 | - | $0.00(0.0%) |
Mar 2018 | - | $0.00(0.0%) |
Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2017 | - | $0.00(0.0%) |
Jun 2017 | - | $0.00(0.0%) |
Mar 2017 | - | $0.00 |
Dec 2016 | $0.00 | - |
FAQ
- What is Unity Biotechnology annual total debt?
- What is the all time high annual total debt for Unity Biotechnology?
- What is Unity Biotechnology annual total debt year-on-year change?
- What is Unity Biotechnology quarterly total debt?
- What is the all time high quarterly total debt for Unity Biotechnology?
- What is Unity Biotechnology quarterly total debt year-on-year change?
What is Unity Biotechnology annual total debt?
The current annual total debt of UBX is $26.99 M
What is the all time high annual total debt for Unity Biotechnology?
Unity Biotechnology all-time high annual total debt is $63.50 M
What is Unity Biotechnology annual total debt year-on-year change?
Over the past year, UBX annual total debt has changed by -$23.47 M (-46.51%)
What is Unity Biotechnology quarterly total debt?
The current quarterly total debt of UBX is $20.70 M
What is the all time high quarterly total debt for Unity Biotechnology?
Unity Biotechnology all-time high quarterly total debt is $63.50 M
What is Unity Biotechnology quarterly total debt year-on-year change?
Over the past year, UBX quarterly total debt has changed by -$3.73 M (-15.28%)